Çocuk ve Ergenlerde Huzursuz Bacak Sendromu
Özet
Huzursuz Bacak Sendromu (HBS), çocuklarda ve ergenlerde bacaklarda kontrol edilemez bir hareket etme dürtüsü ve rahatsız edici hislerle karakterize, özellikle dinlenme anlarında ve akşam saatlerinde şiddetlenen duyusal-motor bir bozukluktur. Tanı süreci, spesifik bir biyobelirteç bulunmadığı için klinik kriterlere dayanmakta olup, semptomların hareketle rahatlaması ve sirkadiyen ritimle uyumu temel ayırt edici özelliklerdir. Patofizyolojisinde genetik yatkınlık, santral dopaminerjik sistem disfonksiyonu ve düşük demir depoları kritik rol oynamaktadır. Çocuklarda yaygın olarak büyüme ağrıları, DEHB ve uyku bozuklukları ile karıştırılabilen bu durum, hastaların yaşam kalitesini ve nörobilişsel gelişimini olumsuz etkilemektedir. Tedavi yaklaşımı öncelikle uyku hijyeni, fiziksel aktivite ve tetikleyici maddelerden kaçınma gibi farmakolojik olmayan yöntemleri içerirken; orta ve şiddetli vakalarda demir takviyesi ilk basamak medikal seçenek olarak öne çıkmaktadır. FDA onaylı bir çocukluk çağı ilacı bulunmamasına rağmen, dirençli durumlarda dopaminerjik ajanlar, antikonvülzanlar ve benzodiazepinler düşük dozlarda ve dikkatli bir titrasyonla kullanılabilmektedir. Erken teşhis ve uygun yönetim, çocukların akademik performansını ve ruh sağlığını iyileştirmek açısından hayati önem taşımaktadır.
Restless Legs Syndrome (RLS) is a sensorimotor disorder in children and adolescents characterized by an uncontrollable urge to move the legs and uncomfortable sensations, which typically intensify during rest and in the evening. Diagnosis relies on clinical criteria, such as relief with movement and alignment with circadian rhythms, as there are no specific biological markers. Genetic predisposition, central dopaminergic system dysfunction, and low iron stores play critical roles in its pathophysiology. Often confused with growing pains, ADHD, and sleep disorders in children, this condition negatively impacts quality of life and neurocognitive development. The treatment approach primarily includes non-pharmacological methods like sleep hygiene, physical activity, and avoiding triggers, while iron supplementation stands out as the first-line medical option for low ferritin levels. Although there are no FDA-approved medications specifically for children, dopaminergic agents, anticonvulsants, and benzodiazepines may be used at low doses with careful titration in resistant cases. Early diagnosis and appropriate management are vital for improving children's academic performance and mental health.
Referanslar
Willis T. The London Practice of physick.1st ed, London, Basset ve Crookee; 1685:404.
Ekbom KA. Restless Legs. Acta Med. Scand Suppl, 1945;158:1-123
Cogen JD, Loghmanee DA. Sleep-Related Movement Disorders. In: Sheldon SH, Ferber R, Kryger MH, Gozal D, Editor. Principles and Practice of Pediatric Sleep Medicine. 2nd ed. Elseiver; 2014.pp.333-36.
American Academy of Sleep Medicine. International classification of sleep disorders, 2nd ed. Diagnostic and coding manual. Westchester, Illinois: American Academy of Sleep Medicine, 2005.
Picchietti DL, Stevens HE. Early manifestations of restless legs syndrome in childhood and adolescence. Sleep Med. 2008;9(7):770-781. doi:10.1016/j.sleep.2007.08.012
Picchietti DL, Arbuckle RA, Abetz L, et al. Pediatric restless legs syndrome: analysis of symptom descriptions and drawings. J Child Neurol. 2011;26(11):1365-1376. doi:10.1177/0883073811405852
Nagandla K, De S. Restless legs syndrome: pathophysiology and modern management. Postgrad Med J. 2013;89(1053):402-410. doi:10.1136/postgradmedj-2012-131634
Teive HA, Munhoz RP, Barbosa ER. Professor Karl-Axel Ekbom and restless legs syndrome. Parkinsonism Relat Disord. 2009;15(4):254-257. doi:10.1016/j.parkreldis.2008.07.011
Abetz L, Allen R, Follet A, et al. Evaluating the quality of life of patients with restless legs syndrome. Clin Ther. 2004;26(6):925-935. doi:10.1016/s0149-2918(04)90136-1
Per H, Günay N, İsmailoğulları S, et al. Determination of restless legs syndrome prevalence in children aged 13-16 years in the provincial center of Kayseri. Brain Dev. 2018;40(3):256-257. doi:10.1016/j.braindev.2017.08.007
Walters AS, Picchietti DL, Ehrenberg BL, et al. Restless legs syndrome in childhood and adolescence. Pediatr Neurol. 1994;11(3):241-245. doi:10.1016/0887-8994(94)90110-4
Akpinar S. Treatment of restless legs syndrome with levodopa plus benserazide. Arch Neurol. 1982;39(11):739. doi:10.1001/archneur.1982.00510230065027
Sevim S, Dogu O, Camdeviren H, et al. Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology. 2003;61(11):1562-1569. doi:10.1212/01.wnl.0000096173.91554.b7
Picchietti DL. Restless Legs Syndrome. In: Kothare SV, Kotagal S, Editor. Sleep in Childhood Neurological Disorders. New York. Demos Medical; 2011.pp.57-70.
Chokroverty S. Editor's corner: restless legs syndrome, a common disease uncommonly diagnosed. Sleep Med. 2003;4(2):91-93. doi:10.1016/s1389-9457(03)00008-x
Picchietti D, Allen RP, Walters AS, et al. Restless legs syndrome: prevalence and impact in children and adolescents--the Peds REST study. Pediatrics. 2007;120(2):253-266. doi:10.1542/peds.2006-2767
Yilmaz K, Kilincaslan A, Aydin N, et al. Prevalence and correlates of restless legs syndrome in adolescents. Dev Med Child Neurol. 2011;53(1):40-47. doi:10.1111/j.1469-8749.2010.03796.x
Turkdogan D, Bekiroglu N, Zaimoglu S. A prevalence study of restless legs syndrome in Turkish children and adolescents. Sleep Med. 2011;12(4):315-321. doi:10.1016/j.sleep.2010.08.013
Kotagal S, Silber MH. Childhood-onset restless legs syndrome. Ann Neurol. 2004;56(6):803-807. doi:10.1002/ana.20292
Tan, E. K. (2007). Genetics of restless legs syndrome: evidence for a hereditary disorder. Journal of Neurology, 254(5), 68-73.
Spiegelhalder K, Hornyak M. Restless legs syndrome in older adults. Clin Geriatr Med. 2008;24(1):167-ix. doi:10.1016/j.cger.2007.08.004
Montplaisir J, Boucher S, Poirier G, et al. polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord. 1997;12(1):61-65. doi:10.1002/mds.870120111
Berger K, Luedemann J, Trenkwalder C, et al. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med. 2004;164(2):196-202. doi:10.1001/archinte.164.2.196
Allen RP. Controversies and challenges in defining the etiology and pathophysiology of restless legs syndrome. Am J Med. 2007;120(1 Suppl 1):S13-S21. doi:10.1016/j.amjmed.2006.11.003
Freeman AA, Rye DB. The molecular basis of restless legs syndrome. Curr Opin Neurobiol. 2013;23(5):895-900. doi:10.1016/j.conb.2013.07.001
Pichler I, Hicks AA, Pramstaller PP. Restless legs syndrome: an update on genetics and future perspectives. Clin Genet. 2008;73(4):297-305. doi:10.1111/j.1399-0004.2007.00937.x
Liebetanz KM, Winkelmann J, Trenkwalder C, et al. RLS3: fine-mapping of an autosomal dominant locus in a family with intrafamilial heterogeneity. Neurology. 2006;67(2):320-321. doi:10.1212/01.wnl.0000224886.65213.b5
Shaw PJ, Duntley SP. Neurological disorders: towards a mechanistic understanding of restless legs syndrome. Curr Biol. 2012;22(12):R485-R486. doi:10.1016/j.cub.2012.05.004
Paulus W, Dowling P, Rijsman R, et al. Pathophysiological concepts of restless legs syndrome. Mov Disord. 2007;22(10):1451-1456. doi:10.1002/mds.21533
Filiz MB, Çakir T. Restless legs syndrome with current diagnostic criteria. Turk Osteoporoz Dergisi. 2015;21(2).
Durmer JS. Restless Legs Syndrome, Periodic Leg Movements and Periodic Limb Movement Disorder. In: Sheldon SH, Ferber R, Kryger MH, Gozal D, Editor. Principles and Practice of Pediatric Sleep Medicine. 2nd ed. Elseiver; 2014.pp.337- 50.
Ondo WG. Restless legs syndrome: pathophysiology and treatment. Curr Treat Options Neurol. 2014;16(11):317. doi:10.1007/s11940-014-0317-2
Merlino G, Valente M, Serafini A, et al. Restless legs syndrome: diagnosis, epidemiology, classification and consequences. Neurol Sci. 2007;28 Suppl 1:S37-S46. doi:10.1007/s10072-007-0736-x
Baier PC, Trenkwalder C. Circadian variation in restless legs syndrome. Sleep Med. 2007;8(6):645-650. doi:10.1016/j.sleep.2006.10.011
Hening WA. Restless legs syndrome: a sensorimotor disorder of sleep/wake motor regulation. Curr Neurol Neurosci Rep. 2002;2(2):186-196. doi:10.1007/s11910-002-0029-y
Rizzo G, Manners D, Testa C, et al. Low brain iron content in idiopathic restless legs syndrome patients detected by phase imaging. Mov Disord. 2013;28(13):1886-1890. doi:10.1002/mds.25576
Yeh P, Walters AS, Tsuang JW. Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment. Sleep Breath. 2012;16(4):987-1007. doi:10.1007/s11325-011-0606-x
Tilma J, Tilma K, Norregaard O, et al. Early childhood-onset restless legs syndrome: symptoms and effect of oral iron treatment. Acta Paediatr. 2013;102(5):e221-e226. doi:10.1111/apa.12173
Mindell, J. A., & Owens, J. A. (2015). A clinical guide to pediatric sleep: diagnosis and management of sleep problems. Lippincott Williams & Wilkins.
Manconi M, Govoni V, De Vito A, et al. Restless legs syndrome and pregnancy. Neurology. 2004;63(6):1065-1069. doi:10.1212/01.wnl.0000138427.83574.a6
Tunç T, Karadağ YS, Doğulu F, et al. Predisposing factors of restless legs syndrome in pregnancy. Mov Disord. 2007;22(5):627-631. doi:10.1002/mds.21291
Banno K, Delaive K, Walld R, et al. Restless legs syndrome in 218 patients: associated disorders. Sleep Med. 2000;1(3):221-229. doi:10.1016/s1389-9457(00)00023-x
Wetter TC, Stiasny K, Kohnen R, et al. Polysomnographic sleep measures in patients with uremic and idiopathic restless legs syndrome. Mov Disord. 1998;13(5):820-824. doi:10.1002/mds.870130511
Merlino G, Fratticci L, Valente M, et al. Association of restless legs syndrome in type 2 diabetes: a case-control study. Sleep. 2007;30(7):866-871. doi:10.1093/sleep/30.7.866
Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4(2):101-119. doi:10.1016/s1389-9457(03)00010-8
Hening WA, Caivano CK. Restless legs syndrome: a common disorder in patients with rheumatologic conditions. Semin Arthritis Rheum. 2008;38(1):55-62. doi:10.1016/j.semarthrit.2007.09.001
http://irlssg.org/diagnostic-criteria, Erişim tarihi: 29 Ağustos 2016
Allen RP, Picchietti DL, Garcia-Borreguero D, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria -history, rationale, description, and significance. Sleep Med. 2014;15(8):860-873. doi:10.1016/j.sleep.2014.03.025
Picchietti DL, Bruni O, de Weerd A, et al. Pediatric restless legs syndrome diagnostic criteria: an update by the International Restless Legs Syndrome Study Group. Sleep Med. 2013;14(12):1253-1259. doi:10.1016/j.sleep.2013.08.778
American Academy of Sleep Medicine. International classification of sleep disorders: a guide to diagnosis and coding. 3rd edition. Westchester: American Academy of Sleep Medicine, 2014: 282-283.
Evans AM, Scutter SD. Prevalence of "growing pains" in young children. J Pediatr. 2004;145(2):255-258. doi:10.1016/j.jpeds.2004.04.045
Wong MW, Williamson BD, Qiu W, et al. Growing pains and periodic limb movements of sleep in children. J Paediatr Child Health. 2014;50(6):455-460. doi:10.1111/jpc.12493
Walters AS, Gabelia D, Frauscher B. Restless legs syndrome (Willis-Ekbom disease) and growing pains: are they the same thing? A side-by-side comparison of the diagnostic criteria for both and recommendations for future research. Sleep Med. 2013;14(12):1247-1252. doi:10.1016/j.sleep.2013.07.013
Manconi M, Ferri R, Zucconi M, et al. Dissociation of periodic leg movements from arousals in restless legs syndrome. Ann Neurol. 2012;71(6):834-844. doi:10.1002/ana.23565
Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome. Lancet Neurol. 2005;4(8):465-475. doi:10.1016/S1474-4422(05)70139-3
Dosman C, Witmans M, Zwaigenbaum L. Iron's role in paediatric restless legs syndrome - a review. Paediatr Child Health. 2012;17(4):193-197. doi:10.1093/pch/17.4.193
Einollahi B, Izadianmehr N. Restless leg syndrome: a neglected diagnosis. Nephrourol Mon. 2014;6(5):e22009. Published 2014 Sep 5. doi:10.5812/numonthly.22009
Gamaldo CE, Earley CJ. Restless legs syndrome: a clinical update. Chest. 2006;130(5):1596-1604. doi:10.1378/chest.130.5.1596
Picchietti MA, Picchietti DL. Restless legs syndrome and periodic limb movement disorder in children and adolescents. Semin Pediatr Neurol. 2008;15(2):91-99. doi:10.1016/j.spen.2008.03.005
Winkelman JW, Allen RP, Tenzer P, Hening W. Restless legs syndrome: nonpharmacologic and pharmacologic treatments. Geriatrics. 2007;62(10):13-16.
Aukerman MM, Aukerman D, Bayard M, Tudiver F, Thorp L, Bailey B. Exercise and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med. 2006;19(5):487-493. doi:10.3122/jabfm.19.5.487
Dinkins EM, Stevens-Lapsley J. Management of symptoms of Restless Legs Syndrome with use of a traction straight leg raise: a preliminary case series. Man Ther. 2013;18(4):299-302. doi:10.1016/j.math.2012.11.002
Bega D, Malkani R. Alternative treatment of restless legs syndrome: an overview of the evidence for mind-body interventions, lifestyle interventions, and neutraceuticals. Sleep Med. 2016;17:99-105. doi:10.1016/j.sleep.2015.09.009
Klingelhoefer L, Cova I, Gupta S, Chaudhuri KR. A review of current treatment strategies for restless legs syndrome (Willis-Ekbom disease). Clin Med (Lond). 2014;14(5):520-524. doi:10.7861/clinmedicine.14-5-520
Hening WA. Current guidelines and standards of practice for restless legs syndrome. Review. Am J Med 2007;120(1 Suppl 1):22-7.
Silber MH, Ehrenberg BL, Allen RP, et al. An algorithm for the management of restless legs syndrome [published correction appears in Mayo Clin Proc. 2004 Oct;79(10):1341]. Mayo Clin Proc. 2004;79(7):916-922. doi:10.4065/79.7.916
DelRosso L, Bruni O. Treatment of pediatric restless legs syndrome. Advances in Pharmacology. 2019; 84, 237-253.
Molokwu OC. Appropriate use of dopamine agonists and levodopa in restless legs syndrome in an ambulatory care setting. Ann Pharmacother. 2008;42(5):627-632. doi:10.1345/aph.1K667
Walters AS, Mandelbaum DE, Lewin DS, et al. Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Dopaminergic Therapy Study Group. Pediatr Neurol. 2000;22(3):182-186. doi:10.1016/s0887-8994(99)00152-6
Konofal E, Arnulf I, Lecendreux M, et al. Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome. Pediatr Neurol. 2005;32(5):350-351. doi:10.1016/j.pediatrneurol.2004.11.007
Mackie S, Winkelman JW. Long-Term Treatment of Restless Legs Syndrome (RLS): An Approach to Management of Worsening Symptoms, Loss of Efficacy, and Augmentation. CNS Drugs. 2015;29(5):351-357. doi:10.1007/s40263-015-0250-2.
Acar S, Gencer AM. Huzursuz bacak sendromunda güncel tedavi. Romatizma Dergisi.2005:20; 59-65
Allen RP, Earley CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep. 1996;19(3):205-213. doi:10.1093/sleep/19.3.205
Garcia-Borreguero D, Grunstein R, Sridhar G, et al. A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome. Sleep Med. 2007;8(7-8):742-752. doi:10.1016/j.sleep.2006.09.009
Garcia-Borreguero D, Larrosa O, de la Llave Y, et al. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology. 2002;59(10):1573-1579. doi:10.1212/wnl.59.10.1573
Newcorn JH, Schulz K, Harrison M, et al. Alpha 2 adrenergic agonists. Neurochemistry, efficacy, and clinical guidelines for use in children. Pediatr Clin North Am. 1998;45(5):1099-viii. doi:10.1016/s0031-3955(05)70064-x
Horiguchi J, Inami Y, Sasaki A, et al. Periodic leg movements in sleep with restless legs syndrome: effect of clonazepam treatment. Jpn J Psychiatry Neurol. 1992;46(3):727-732. doi:10.1111/j.1440-1819.1992.tb00548.x
Bogan RK. Ropinirole treatment for restless legs syndrome. Expert Opin Pharmacother. 2008;9(4):611-623. doi:10.1517/14656566.9.4.611
Verrotti A, Prezioso G, Di Sabatino F, et al. The adverse event profile of levetiracetam: A meta-analysis on children and adults. Seizure. 2015;31:49-55. doi:10.1016/j.seizure.2015.07.004
Gagliano A, Aricò I, Calarese T, et al. Restless Leg Syndrome in ADHD children: levetiracetam as a reasonable therapeutic option. Brain Dev. 2011;33(6):480-486. doi:10.1016/j.braindev.2010.09.008
Prince JB, Wilens TE, Biederman J,et al. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. J Am Acad Child Adolesc Psychiatry. 1996;35(5):599-605. doi:10.1097/00004583-199605000-00014
Oran M, Unsal C, Albayrak Y, et al. Possible association between vitamin D deficiency and restless legs syndrome. Neuropsychiatr Dis Treat. 2014;10:953-958. Published 2014 May 21. doi:10.2147/NDT.S63599
Whittom S, Dumont M, Petit D, et al. Effects of melatonin and bright light administration on motor and sensory symptoms of RLS. Sleep Med. 2010;11(4):351-355. doi:10.1016/j.sleep.2009.12.008
